Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (49)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
1970 • 253,849 citations
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
1949 • 19,979 citations
Plasminogen activator inhibitors
1987 • 957 citations
Plasminogen activator inhibitors
1987 • 764 citations
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
1985 • 731 citations
An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.
1979 • 727 citations
Synthesis of fibrinolytic activator and inhibitor by endothelial cells
1977 • 484 citations
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
1983 • 479 citations
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.
1987 • 479 citations
Synthesis of fibronectin by cultured human endothelial cells.
1978 • 458 citations
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
1985 • 450 citations
Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
1982 • 362 citations
Autocrine saturation of pro-urokinase receptors on human A431 cells
1986 • 361 citations
Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma
1984 • 345 citations
Binding of plasminogen to cultured human endothelial cells.
1986 • 311 citations
Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.
1986 • 310 citations
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay
1988 • 262 citations
Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
1984 • 253 citations
Receptor Binding Studies in Adrenergic Pharmacology
1978 • 240 citations
Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions
1984 • 240 citations
Plasminogen activator release during venous stasis and exercise as determined by a new specific assay
1983 • 238 citations
Binding of tissue plasminogen activator to cultured human endothelial cells.
1987 • 223 citations
An endothelial cell-dependent pathway of coagulation.
1985 • 212 citations
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.
1985 • 207 citations
N-Terminal Disulphide Knot of Human Fibrinogen
1968 • 199 citations
Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor
1987 • 188 citations
Binding of plasminogen to extracellular matrix.
1986 • 175 citations
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
1987 • 170 citations
Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
1984 • 159 citations
Complex formation of platelet thrombospondin with histidine-rich glycoprotein.
1984 • 151 citations
Fc and C3 Receptors Induced by Herpes Simplex Virus on Cultured Human Endothelial Cells
1982 • 148 citations
Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells
1986 • 130 citations
Studies on the Fibrinolytic System in Human Plasma: Quantitative Determination of Plasminogen Activators and Proactivators
1979 • 123 citations
Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein
1978 • 111 citations
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction
1987 • 109 citations
Sustained Fibrinolysis After Administration of t-PA Despite Its Short Half-Life in the Circulation
1987 • 107 citations
Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.
1988 • 89 citations
Receptor Binding Studies in Adrenergic Pharmacology
1979 • 84 citations
Binding of tissue plasminogen activator to human umbilical vein endothelial cells
1987 • 77 citations
Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
1984 • 77 citations
Pharmacokinetics and Effects on Fibrinolytic and Coagulation Parameters of Two Doses of Recombinant Tissue-Type Plasminogen Activator in Healthy Volunteers
1986 • 72 citations
Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.
1985 • 72 citations
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis
1986 • 71 citations
Cryptic urokinase binding sites on human foreskin fibroblasts
1985 • 71 citations
Physiologic and Pharmacologic Enhancement of Fibrinolysis
1984 • 65 citations
Characterization and properties of cultured human von Willebrand umbilical vein endothelial cells
1981 • 57 citations
Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes.
1987 • 56 citations
Serum-mediated suppression of cell-associated plasminogen activator activity in cultured endothelial cells
1980 • 51 citations
An improved microtiter plate method to measure the potency of plasminogen activators
1984 • 3 citations
Cited By (0)
No citing papers found in database